• About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
Menu
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
NEWS
RESOURCES
PODCAST
  • NEWS
  • RESOURCES
  • PODCAST
  • VIDEOS
  • CONTACT
Donate
Subscribe
Search
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
Menu
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
AHSCT awakens EBV in MS, yet relapse remains at bay 25 October 2023
MS News MS Trials
AHSCT awakens EBV in MS, yet relapse remains at bay
Rest assured: DMTs won’t disrupt your sleep 25 October 2023
MS News MS Trials
Rest assured: DMTs won’t disrupt your sleep
Breaking the fall: reactive balance training shows promise in reducing falls in people with MS 27 September 2023
MS Brainbank MS News MS Trials
Breaking the fall: reactive balance training shows promise in reducing falls in people with MS
Examining How Early Relapses Shape MS Disability Progression 26 September 2023
MS Brainbank MS Trials
Examining How Early Relapses Shape MS Disability Progression
Australian researchers develop a highly effective new EBV vaccine 31 August 2023
MS Brainbank MS News MS Trials
Australian researchers develop a highly effective new EBV vaccine
Exploring Promising MS Treatment: Understanding the Potential of Stem Cell Therapy 31 August 2023
MS Brainbank MS News MS Trials
Exploring Promising MS Treatment: Understanding the Potential of Stem Cell Therapy
Comparing treatment options after stopping natalizumab 31 August 2023
MS Brainbank MS News MS Trials
Comparing treatment options after stopping natalizumab
MS Australia’s 2023 Incubator Grants: Advancing Innovative MS Research 30 August 2023
MS Brainbank MS News MS Trials
MS Australia’s 2023 Incubator Grants: Advancing Innovative MS Research
Revealing How a Natural Compound May Affect Nerve Cell Protection in MS 25 July 2023
MS Brainbank MS Trials
Revealing How a Natural Compound May Affect Nerve Cell Protection in MS
Family planning and MS: Understanding information needs 25 July 2023
MS Brainbank MS Trials
Family planning and MS: Understanding information needs
Load More
MS Australia
registered charity

1300 010 158

info@msaustralia.org.au

Head Office

Suite 3.01, 18 Flour Mill Way
Summer Hill NSW 2130

Participate in MS Research

  • MS Clinical Trials
  • MS Australia Brain Bank
  • Australian MS Longitudinal Study
Facebook-f X-twitter Linkedin-in Youtube Spotify Paper-plane

Quick links

  • What is MS?
  • How is MS diagnosed?
  • COVID-19 and MS
  • Research funding opportunities
  • Research we fund
  • Media enquiries
  • Contact us
© 2025 Multiple Sclerosis Australia | ABN: 51 008 515 508 │Privacy Policy | Whistleblower Policy | Complaints Policy | Terms and Conditions
© 2024 Multiple Sclerosis Australia
ABN: 51 008 515 508
Privacy Policy | Whistleblower Policy
Complaints Policy | Terms and Conditions
SUBSCRIBE
DONATE
CONTACT

Newsletter subscription

  • Enter your details

AHSCT awakens EBV in MS, yet relapse remains at bay